River Vest Venture Management LLC Otonomy, Inc. Transaction History

River Vest Venture Management LLC

  • $6.84 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Aug 11, 2021
SELL
$2.49 - $6.23 $1.25 Million - $3.13 Million
-501,899 Closed
0 $0
Q4 2020

Aug 11, 2021
BUY
$3.48 - $6.47 $1.75 Million - $3.25 Million
501,899 New
501,899 $3.25 Million

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track River Vest Venture Management LLC Portfolio

Follow River Vest Venture Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Vest Venture Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Vest Venture Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email